Last reviewed · How we verify

NCT05490069

The Effect of Instant Message Intervention for Psychological Well-being Among Stroke Survivors

Completed NA Last updated 1 May 2023
What this trial tests

NA trial testing iCBT-based EMI in Stroke in 40 participants. Completed in 23 December 2022.

Timeline
4 October 2021
Primary endpoint
23 December 2022
23 December 2022

Quick facts

Lead sponsorThe University of Hong Kong
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment40
Start date4 October 2021
Primary completion23 December 2022
Estimated completion23 December 2022
Sites7 locations across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

18 and older, any sex, with Stroke or Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed pilot trial aims to evaluate the feasibility of iCBT based EMI, which is a real-time, real-world, personalised and cost-effective approach, for stroke survivors' psychological well-being.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of iCBT-based EMI

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05490069.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing